Shirvan Mitchell

Shirvan Mitchell is listed in filings as CSO and CDO at Silexion Therapeutics Ltd.. This profile follows SEC Form 4 activity through Mar 30, 2026, including sale activity. Recent filings connect the profile to Silexion Therapeutics Ltd. (SLXN). The current snapshot covers public activity from Feb 23, 2026 to Mar 30, 2026. Reported amounts are shown as $31.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.